SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-008561
Filing Date
2021-04-12
Accepted
2021-04-12 17:14:23
Documents
12
Period of Report
2021-04-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 48529
2 ex1-1.htm EX-1.1 55597
3 ex4-1.htm EX-4.1 120294
4 ex4-2.htm EX-4.2 113891
5 ex4-3.htm EX-4.3 116702
6 ex5-1.htm EX-5.1 13893
7 ex10-1.htm EX-10.1 310670
8 ex10-2.htm EX-10.2 34172
9 ex99-1.htm EX-99.1 13980
10 ex5-1_002.jpg GRAPHIC 14235
11 ex5-1_001.jpg GRAPHIC 10344
12 ex99-1_001.jpg GRAPHIC 6860
  Complete submission text file 0001493152-21-008561.txt   872713
Mailing Address 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ 08852
Business Address 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ 08852 732 545 1590
Advaxis, Inc. (Filer) CIK: 0001100397 (see all company filings)

IRS No.: 841521955 | State of Incorp.: DE | Fiscal Year End: 1031
Type: 8-K | Act: 34 | File No.: 001-36138 | Film No.: 21821395
SIC: 2834 Pharmaceutical Preparations